iC9.GD2.CAR.IL-15 T-cells
LCCC 1743-ATL
Phase 1 mab active
Quick answer
iC9.GD2.CAR.IL-15 T-cells for Neuroblastoma is a Phase 1 program (mab) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Neuroblastoma
- Phase
- Phase 1
- Modality
- mab
- Status
- active